study_start,study_end,eligible_patients,treated_patients,treated_paxlovid,treated_sotrovimab,treated_remdesivir,treated_molnupiravir,treated_casirivimab,high_risk_cohort_2plus,high_risk_cohort_lower,high_risk_cohort_upper
2021-12-11,2023-01-19,155530,39870,14350,16760,100,8620,50,26090,1,7
